Immunization Action Coalition and the Hepatitis B Coalition

IAC EXPRESS

Previous issues index

Home page

Issue Number 589            March 27, 2006

CONTENTS OF THIS ISSUE

  1. New: AAP endorses CDC's hepatitis B recommendations for infants, children, and adolescents
  2. Here's a resource to help you talk with parents about thimerosal
  3. MMWR publishes ACIP's tetanus, diphtheria, and pertussis recommendations for adolescents
  4. Current Issues in Immunization net conference to focus on general recommendations and rotavirus recommendations
  5. April 11 teleconference to discuss human papillomavirus disease and vaccine
  6. HHS adds more influenza antiviral medication to the nation's stockpile
  7. CDC adds to and updates its Influenza web section
  8. Pandemic Influenza website adds planning checklists for colleges/universities and child care/preschools
  9. Updated: IAC revises a Spanish-language adolescent immunization piece and a professional-education piece
  10. Attention teens: Your PSA on meningococcal disease could be featured on websites, a pod cast, and a DVD

----------------------------------------------------------

Back to Top

---------------------------------------------------------------

ABBREVIATIONS: AAFP, American Academy of Family Physicians; AAP, American Academy of Pediatrics; ACIP, Advisory Committee on Immunization Practices; CDC, Centers for Disease Control and Prevention; FDA, Food and Drug Administration; IAC, Immunization Action Coalition; MMWR, Morbidity and Mortality Weekly Report; NIP, National Immunization Program; VIS, Vaccine Information Statement; VPD, vaccine-preventable disease; WHO, World Health Organization.
---------------------------------------------------------------

(1 of 10)
March 27, 2006
NEW: AAP ENDORSES CDC'S HEPATITIS B RECOMMENDATIONS FOR INFANTS, CHILDREN, AND ADOLESCENTS

The American Academy of Pediatrics (AAP) recently published an article, "Academy endorses CDC's hepatitis B recommendations," in the online version of its publication AAP News. It concerns ACIP's new hepatitis B recommendations, which cover immunization of infants, children, and adolescents. The online AAP News article is reprinted below in its entirety.

********************

The Academy has endorsed the Centers for Disease Control and Prevention (CDC) recommendation for hepatitis B vaccine, "A Comprehensive Immunization Strategy to Eliminate Transmission of Hepatitis B Virus Infection in the United States."

The CDC recommends that all newborns receive a birth dose of hepatitis B vaccine before leaving the hospital unless a physician provides a written order to defer the birth dose. CDC also recommends that all children age 19 and younger receive the vaccine series.

DELAY IN 'RARE CIRCUMSTANCES'
"On a case-by-case basis and only in rare circumstances," the birth dose may be delayed until after hospital discharge, according to the new recommendation. This exception applies only to infants who weigh at least 2,000 grams and whose mothers are known to be HBsAg negative during the current pregnancy. When a decision is made to delay the birth dose, a physician's order to withhold the birth dose and a copy of the original laboratory report indicating that the mother was HBsAg negative during this pregnancy must be placed in the infant's medical record.

In infants who do not receive a first dose before hospital discharge, the first dose should be administered no later than 2 months of age.

CDC recommendations also state that the birth dose should not be delayed if the infant's mother engaged in high-risk sexual or drug-using practices during pregnancy (e.g., having had more than one sex partner during the previous six months or an HBsAg-positive sex partner, evaluation or treatment for an STD, or recent or current injection-drug use) or in situations of expected poor compliance with follow-up to initiate the vaccine series.

Preterm infants weighing less than 2,000 grams and born to HBsAg-negative mothers should have their first vaccine dose delayed until one month after birth or hospital discharge, whichever comes first. For these infants, a copy of the original laboratory report indicating that the mother was HBsAg negative during this pregnancy should be placed in the infant's medical record.

The recommendations call for physician follow-up in infants whose birth dose is delayed.

CATCH-UP
Hepatitis B vaccination is recommended for all children and adolescents 19 years of age and under. Children and adolescents who have not previously received hepatitis B vaccine should be vaccinated routinely at any age with an appropriate dose and schedule, but all children aged 11-12 years should have a review of their immunization records and should complete the vaccine series if they were not previously vaccinated or were incompletely vaccinated.

[The CDC recommendation is online at http://www.cdc.gov/mmwr/PDF/rr/rr5416.pdf or see the Dec. 23, 2005, Morbidity and Mortality Weekly Report (MMWR. 2005;54 (RR-16):1-23)].

Additional information about hepatitis B is available in the 2003 edition of the AAP Red Book (pages 318-336) and on the Red Book Online Web site: aapredbook.aappublications.org
[http://aapredbook.aappublications.org].

********************

To access the article from the AAP News, go to:
http://aapnews.aappublications.org/cgi/content/full/e2006199v1

If you prefer a web-text (HTML) version of the ACIP recommendations, use the following links:

For the main text of the ACIP recommendations, go to:
http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5416a1.htm

For Appendix A (Case finding and management of hepatitis B surface antigen [HBsAg]—positive persons during delivery of vaccination services), go to:
http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5416a2.htm

For Appendix B (Immunization management issues), go to:
http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5416a3.htm

For Appendix C (Postexposure prophylaxis of persons with discrete identifiable exposure to hepatitis B virus [HPV]), go to:
http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5416a4.htm
---------------------------------------------------------------

Back to Top

(2 of 10)
March 27, 2006
HERE'S A RESOURCE TO HELP YOU TALK WITH PARENTS ABOUT THIMEROSAL

During CDC's recent National Immunization Conference (NIC), Paul Offit, MD, delivered a presentation, "Effectively Communicating about Mercury in Vaccines to Concerned Parents." CDC has now posted both a handout and recording of the presentation on its website. To access them, go to: http://www.cdc.gov/nip/nic Scroll down to the heading Conference Recordings and Slides, and click on the Go icon next to "proceed to the online Conference Program." Scroll down to the calendar for March 7; click on Featured Presentation in the 11AM-12PM time slot and then click on Paul Offit's presentation.

Dr. Offit, who was selected to deliver the Jeryl Lynn Hilleman Endowed Lecture at NIC, is chief, Division of Infectious Diseases, Children's Hospital of Philadelphia, and professor of pediatrics and Maurice R. Hilleman Professor of Vaccinology, University of Pennsylvania School of Medicine.
---------------------------------------------------------------

Back to Top

(3 of 10)
March 27, 2006
MMWR PUBLISHES ACIP'S TETANUS, DIPHTHERIA, AND PERTUSSIS RECOMMENDATIONS FOR ADOLESCENTS

On March 24, CDC published "Preventing Tetanus, Diphtheria, and Pertussis Among Adolescents: Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccines" in MMWR Recommendations and Reports. Previously, the article was available only in electronic format as an MMWR Early Release.

To access a ready-to-print (PDF) version of the recommendations, which includes all the appendices, go to: http://www.cdc.gov/mmwr/PDF/rr/rr5503.pdf

To access a web-text (HTML) version of the recommendations, go to: http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5503a1.htm The web-text version does not contain the six appendices. To access them, click on the following links:

Appendix A (Composition of selected vaccines with tetanus toxoid, diphtheria toxoid, and acellular pertussis components licensed in the United States, 2006):
http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5503a2.htm

Appendix B (CDC and Council of State and Territorial Epidemiologists (CSTE) pertussis case definition):
http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5503a3.htm

Appendix C (Summary of recommendations for tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine [Tdap] and tetanus and diphtheria toxoids [Td] use among adolescents aged 11—18 years):
http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5503a4.htm

Appendix D (Guide to catch-up vaccination with Td and Tdap for adolescents aged 11—18 years):
http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5503a5.htm

Appendix E (Guide to catch-up vaccination with Td for children aged 7—10 years):
http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5503a6.htm

Appendix F (Abbreviations used in this report):
http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5503a7.htm
---------------------------------------------------------------

Back to Top

(4 of 10)
March 27, 2006
CURRENT ISSUES IN IMMUNIZATION NET CONFERENCE TO FOCUS ON GENERAL RECOMMENDATIONS AND ROTAVIRUS RECOMMENDATIONS

Scheduled for April 20 from noon to 1PM ET, the net conference Current Issues in Immunization is designed to provide clinicians with up-to-date information on immunization. The program has two primary topics: (1) general recommendations (timing and spacing of immunobiologics and altered immunocompetence) and (2) rotavirus vaccine recommendations.

The conference requires pre-registration, as space is limited. Registration will close when the course is full or on April 17 (midnight ET). To register for the conference, go to:
http://www2.cdc.gov/nip/isd/ciinc

The program will combine a telephone audio conference and simultaneous online visual content. Participants can join the Q&A session by telephone or Internet. For instructions and system requirements, go to:
http://www.cdc.gov/nip/ed/ciinc/instructions.htm

For additional information, email nipinfo@cdc.gov
---------------------------------------------------------------

Back to Top

(5 of 10)
March 27, 2006
APRIL 11 TELECONFERENCE TO DISCUSS HUMAN PAPILLOMAVIRUS DISEASE AND VACCINE

The National Immunization Coalition TA [technical assistance] Network has scheduled a teleconference that will focus on human papillomavirus (HPV) disease and vaccine and on outreach messages to use with healthcare providers. It will be held on April 11 at 2:00PM ET.

NOTE: CDC will give updates on the current influenza vaccine supply at the beginning of this teleconference and at the beginning of future teleconferences throughout the influenza season.

The presenter is Anna Giuliano, PhD, a leader for risk assessment, detection, and intervention programs at the H. Lee Moffitt Cancer Center & Research Institute, University of South Florida, Tampa. The National Institutes of Health recently awarded $10 million to Dr. Giuliano for a study to determine men's role in the spread of HPV.

To register for the teleconference, send an email to IZTA@aed.org Include this message: "Sign me up for the HPV discussion."

For additional information, or to access earlier programs, go to: http://www.izcoalitionsta.org/confcall.cfm
---------------------------------------------------------------

Back to Top

(6 of 10)
March 27, 2006
HHS ADDS MORE INFLUENZA ANTIVIRAL MEDICATION TO THE NATION'S STOCKPILE

On March 22, the Department of Health and Human Services (HHS) issued a press release announcing that it had purchased 6 million additional treatment courses of two influenza antiviral drugs. The opening paragraph of the release is reprinted below.

*******************

For immediate release
Wednesday, March 22, 2006

HHS BUYS MORE ANTIVIRAL MEDICATION FOR THE STRATEGIC NATIONAL STOCKPILE

HHS Secretary Mike Leavitt today announced additional purchases of antiviral drugs that could be used in the event of a potential influenza pandemic. The department has ordered 2.2 million more treatment courses of antiviral drug zanamivir (Relenza) from GlaxoSmithKline and 3.8 million more treatment courses of oseltamivir phosphate (Tamiflu) from Roche. With these purchases, the Strategic National Stockpile will have a total of 26 million treatment courses of antiviral drugs for distribution to the states when an influenza pandemic is deemed to be imminent. . . .

*******************

To access the complete press release, go to:
http://www.hhs.gov/news/press/2006pres/20060322.html
---------------------------------------------------------------

Back to Top

(7 of 10)
March 27, 2006
CDC ADDS TO AND UPDATES ITS INFLUENZA WEB SECTION

CDC recently added to and updated reports on its Influenza web section. These include reports on avian influenza: the embargo of birds from Afghanistan and Israel; countries added to the list of those reporting human cases (Azerbaijan); and countries added to the list of those reporting animal cases (Afghanistan). In addition, one report was added on instructions for using software programs to estimate the potential impact of pandemic influenza. Details follow:

NEW

  1. "Amendment to embargo of birds & bird products imported from Afghanistan" (posted 3/22/06)
  2. "Instructions to estimate the potential impact of the next influenza pandemic upon locale Y" (posted 3/22/06)
  3. "Amendment to embargo of birds & bird products imported from Israel" (posted 3/20/06)


To access these resources, go to: http://www.cdc.gov/flu/whatsnew.htm#new and click on the pertinent links.

UPDATED

  1. "Embargo of birds from specified countries [Afghanistan]" (posted 3/22/06)
  2. "Avian influenza: Current situation" (posted 3/21/06)
  3. "Questions & answers about avian influenza (bird flu) & avian influenza virus" (posted 3/20/06)
  4. "Embargo of birds from specified countries [Israel]" (posted 3/20/06)


To access these resources, go to: http://www.cdc.gov/flu/whatsnew.htm#updated and click on the pertinent links.

To access a broad range of continually updated information on seasonal influenza, avian influenza, and pandemic influenza, go to: http://www.cdc.gov/flu
---------------------------------------------------------------

Back to Top

(8 of 10)
March 27, 2006
PANDEMIC INFLUENZA WEBSITE ADDS PLANNING CHECKLISTS FOR COLLEGES/UNIVERSITIES AND CHILD CARE/PRESCHOOLS

On March 21, the federal government posted two new checklists to its Pandemic Influenza website:

1. Colleges and Universities Pandemic Influenza Planning Checklist

To access a ready-to-print (PDF) version, go to:
http://www.pandemicflu.gov/plan/pdf/colleges_universities.pdf

To access a web-text (HTML) version, go to:
http://www.pandemicflu.gov/plan/collegeschecklist.html

2. Child Care and Preschool Pandemic Influenza Planning Checklist

To access a ready-to-print (PDF) version, go to:
http://www.pandemicflu.gov/plan/pdf/child_care.pdf

To access a web-text (HTML) version, go to:
http://www.pandemicflu.gov/plan/preschool.html

To access an array of pandemic influenza resources, visit the website at http://www.pandemicflu.gov
---------------------------------------------------------------

Back to Top

(9 of 10)
March 27, 2006
UPDATED: IAC REVISES A SPANISH-LANGUAGE ADOLESCENT IMMUNIZATION PIECE AND A PROFESSIONAL-EDUCATION PIECE

IAC recently updated the Spanish-language version of its parent-education piece "When do children and teens need vaccinations?" (Cuando necesitan sus vacunas los ninos y los adolescentes?) and its professional-education piece "Maintaining the cold chain during transport."

1. "Cuando necesitan sus vacunas los ninos y los adolescentes?" was updated to reflect new recommendations and licensures.

To access a ready-to-print (PDF) version of it, go to:
http://www.immunize.org/catg.d/p4050-01.pdf

To access a web-text (HTML) version, go to:
http://www.immunize.org/catg.d/p4050-01.htm

2. "Maintaining the cold chain during transport" was revised to reflect information about two newly licensed vaccines, tetanus-diphtheria-pertussis (Tdap) vaccine and measles-mumps-rubella-varicella (MMRV) vaccine.

To access a ready-to-print (PDF) version of it, go to:
http://www.immunize.org/catg.d/p3049.pdf
---------------------------------------------------------------

Back to Top

(10 of 10)
March 27, 2006
ATTENTION TEENS: YOUR PSA ON MENINGOCOCCAL DISEASE COULD BE FEATURED ON WEBSITES, A POD CAST, AND A DVD

The California Distance Learning Health Network (CDLHN) is spreading the word about the importance of meningococcal vaccination and is looking for teens to help. Teens between ages 15-19 are invited to submit an original Public Service Announcement (PSA) that will encourage college freshmen planning to live in dorms to get the meningococcal vaccine.

The selected entry will be featured on the CDLHN website and a teen vaccination website. It will also be included on a DVD on meningococcal disease. This will give the teen's PSA exposure to thousands of people visiting the Web and watching the DVD.

For comprehensive information on the contest, go to:
http://cdlhn.com/podcast.info

 

Immunization Action Coalition1573 Selby AvenueSt. Paul MN 55104
E-mail: admin@immunize.org Web: http://www.immunize.org/
Tel: (651) 647-9009Fax: (651) 647-9131

This page was updated on March 27, 2006